The Detroit Lions' quest to find a consistent bookend for star pass rusher Aidan Hutchinson continues to be a key storyline. While the team took a late-round flier on Ahmed Hassanein last year, another developmental edge rusher could be in the cards for the 2026 NFL Draft. One name on the radar is Indiana's Mikail Kamara, a productive player whose draft stock is heavily influenced by a significant medical history.

Kamara's final collegiate seasons were impressive on the stat sheet, as he battled to play in every game, amassing 45 tackles for loss and 23.5 sacks over his last two years. That toughness and production will certainly intrigue teams looking for a late-round value.

However, a deep dive into his medical report reveals considerable cause for pause. His injury timeline is lengthy, headlined by multiple shoulder surgeries, including procedures on both shoulders for labrum tears dating back to 2020 and 2021. A shoulder nerve stinger in 2025 also requires careful evaluation to rule out any spinal involvement, adding to the complexity.

When you combine this history of significant upper-body injuries with his older age for a prospect, it creates a high medical concern level. For a Lions team that has seen recent investments like Marcus Davenport hampered by health issues, Kamara represents a classic high-risk, high-reward proposition. His draft projection in the later rounds reflects this, making him a player whose medical evaluations during the pre-draft process will be absolutely critical in determining his final landing spot and potential fit in Detroit's defensive rotation.